🇺🇸 FDA

Company profile · Sponsor

Apimeds

Apimeds Pharmaceuticals US

APUS · NYSE pharma MATAWAN, NJ, USA
Pipeline
3
Drugs
0
Patents
0

Quick answer

Apimeds (APUS) is a pharma company. headquartered in MATAWAN, NJ, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker APUS
Exchange NYSE
Company type pharma
Headquarters MATAWAN, NJ, USA
SEC CIK 0001894525

Pipeline (3)

Search pipeline →

  1. Apitox - pure honeybee toxin

    Apimeds

    Multiple Sclerosis

    phase 3 small molecule active

    1 trial

  2. Apitox, purified honeybee toxin, lyophilized in saline

    Apimeds

    Osteoarthritis of the Knee

    phase 3 mab completed

    1 trial

  3. honeybee venom (Apitoxin (Korea) Apitox (USA))

    Apimeds

    Osteoarthritis of the Knee

    phase 2 small molecule completed

    1 trial

Frequently asked questions

What is Apimeds?

Apimeds (APUS) is a pharma company. headquartered in MATAWAN, NJ, USA. listed on NYSE. NovaPharmaNews links 3 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does Apimeds sponsor?

We track 3 ClinicalTrials.gov-linked programs for Apimeds, including Apitox - pure honeybee toxin and 2 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Apimeds company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.